Predictive Markers of Glitazone Efficacy in Diabetic Patients - Pilot Study

NCT00481429 · clinicaltrials.gov ↗

WITHDRAWN

Status

OTHER

Sponsor class

Stopped Unable to recruit enough participants

Conditions

Diabetes Mellitus, Type 2

Interventions

DRUG: Rosiglitazone

Sponsor

Imperial College London

Collaborators

[object Object]